Published on
April 15, 2026
- 07:33 GMT
Geared Power BioTech accepted into the FDA’s Safer Technologies Program for its BioGuard UVC™ device
BioGuard UVC™ is Positioned as Safer Technology to Prevent the Spread of Respiratory Disease by Inactivating Airborne Pathogens Present in Exhaled Breath WAYNE, NJ, UNITED STATES, April 15, 2026 /EINPresswire.com/ -- Geared Power BioTech, a health technology startup, today announced that its flagship product, BioGuard UVC™, meets the eligibility factors for acceptance into the U.S. Food and Drug Administration’s (FDA) Safer Technologies Program (STeP), which includes a reasonable expectation of clinical …
Distribution channels:
Banking, Finance & Investment Industry, Business & Economy
...
